Axsome Therapeutics AXSM
NASDAQ AXSM
$149.07 +8.10 (+5.74%)
As of: Nov 11, 2026 · 2:01 PM EST

Axsome Therapeutics (AXSM) Shares Outstanding (Diluted) (2020 - 2026)

Updated

Axsome Therapeutics (AXSM) recorded Weighted Average Shares Outstanding (Diluted) of 52.45 million in Q3 2026, up 4.8% from 50.02 million a year earlier and up 1.2% from the prior quarter.

Analysis

Axsome Therapeutics (AXSM) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends

For FY2025, Axsome Therapeutics reported Weighted Average Shares Outstanding (Diluted) of 49.75 million, up 3.8% from FY2024.

  • Annual Weighted Average Shares Outstanding (Diluted) has increased for five straight years, with a five-year compound annual growth rate of 6.0% (FY2020 to FY2025).
  • Across earlier years, Weighted Average Shares Outstanding (Diluted) came in at 47.91 million in FY2024 (+5.5%), 45.43 million in FY2023 (+11.7%), 40.66 million in FY2022 (+8.1%) and 37.62 million in FY2021 (+1.1%).
  • The Q3 2026 figure is the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q4 2020.
  • On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) has increased for 20 consecutive quarters, with growth averaging 4.3% over the last eight quarters.
  • Across the past five years, year-over-year growth in Weighted Average Shares Outstanding (Diluted) ran from 1.1% in Q4 2021 to 13.6% in Q1 2023.
  • Per Business Quant, the preceding three quarters came in at 51.8 million (Q2 2026), 51.2 million (Q1 2026) and 49.75 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 893.40 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.45 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.48 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 1.96 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.56 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 546.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.25 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.75 Bn
10 Axsome Therapeutics 7.41 Bn 6.15 Bn 241.89 Mn 52.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 52.45 Mn
Jun 30, 2026 51.80 Mn
Mar 31, 2026 51.20 Mn
Dec 31, 2025 49.75 Mn
Sep 30, 2025 50.02 Mn
Jun 30, 2025 49.44 Mn
Mar 31, 2025 48.87 Mn
Dec 31, 2024 47.91 Mn
Sep 30, 2024 48.14 Mn
Jun 30, 2024 47.57 Mn
Mar 31, 2024 47.39 Mn
Dec 31, 2023 45.43 Mn
Sep 30, 2023 47.12 Mn
Jun 30, 2023 43.67 Mn
Mar 31, 2023 43.52 Mn
Dec 31, 2022 40.66 Mn
Sep 30, 2022 41.70 Mn
Jun 30, 2022 39.08 Mn
Mar 31, 2022 38.32 Mn
Dec 31, 2021 37.62 Mn
API Access

Axsome Therapeutics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=AXSM&period=max&api_key=YOUR_API_KEY